The bank’s hiring practices in Asia have drawn U.S. government scrutiny for possible FCPA violations.
The New Jersey-based power company voluntarily disclosed to the DOJ in March 2012 it was examining possible improper gifts and hospitality in China.
Oral arguments have been scheduled for May in the Ralls Corp. appeal of its partially dismissed lawsuit challenging the Committee on Foreign Investment in the United States.
The California-based pharmaceutical company, under investigation since 2010, disclosed last week it had set aside $2 million for a possible FCPA settlement.
The French pharmaceutical company’s business practices are also under scrutiny in Germany and China.
The case has been followed closely for evidence of how courts are interpreting complicated new whistleblower protections enacted under the 2010 Dodd-Frank Wall Street Reform and Consumer Protection Act.
But China continues to probe in its own anti-corruption sweep of the pharmaceutical industry.
Chinese Premier Li Keqiang said in remarks released Feb. 23 that bidding for construction projects, land-use contracts, and mining rights are three areas that have been prone to corruption.
Investigation Prompted by Hiring of Employee Related to Head of a Chinese Listing Hopeful
By The Global Compliance and Disputes Practice Group
Anti-corruption enforcement efforts in China historically have tended to focus on the recipients of bribery, as evidenced by harsher statutory penalties for bribe takers and the highly publicized prosecution of government officials accused of accepting illicit payments. However, recently issued guidance on PRC anti-bribery law places the focus squarely on bribe [...]
Targeting multinational corporations instead of its own corrupt officials can help the Communist Party save some face, professor Daniel Chow said at a discussion hosted by Fordham Law School and the Chinese Business Lawyers Association.
In a speech, Kathleen Hamann warned compliance officers to be prepared to mediate among multiple jurisdictions, and singled out China for its lack of coordination with other international enforcement agencies.
Paying attorneys’ fees and making compliance changes appears to be a new trend in settling shareholder derivative lawsuits that allege foreign bribery failures. DOCUMENTS attached.
The auditing firms said they could not give documents to the SEC without violating Chinese law. An administrative law judge said the firms “willfully” failed to provide documents to U.S. regulators.
At least three Chinese drug companies are under investigation by China for paying bribes, joining the 10 known Western pharma companies swept up in the probe.
President Barack Obama speaks at outgoing Attorney General Eric Holder's portrait unveiling ceremony.
Attorney General Eric Holder called for a lower bar to federal civil rights prosecutions in an exit interview with Politico's Mike Allen.